David J. Caponera
Keine laufenden Positionen mehr
Karriereverlauf von David J. Caponera
Ehemalige bekannte Positionen von David J. Caponera
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 13.06.2019 | 01.03.2022 |
| CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2014 | 01.07.2018 |
Ausbildung von David J. Caponera
| Cornell University | Undergraduate Degree |
| Duke University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
- Börse
- Insiders
- David J. Caponera
- Erfahrung